Skip to main content
Fig. 2 | BMC Pharmacology and Toxicology

Fig. 2

From: The chemotactic properties of various topical brimonidine tartrate ophthalmic preparations

Fig. 2

X-axis: Migration through the matrix measured in micrometers (μm); Y-axis: each experimental condition, including controls. BT 0.15% without BAK and BAK 0.005% alone had no significant chemotactic effect, while BT 0.2% with BAK 0.005% (Alcon Laboratories Inc.) and BT 0.2% with BAK 0.005% (Allergan Inc.) showed significantly higher chemotactic activity. Both the positive controls, ZAS and fMLP, showed the highest chemotactic effect, demonstrated by the longest migration distances of neutrophils through the matrix, as expected. Cells in the PBS negative control showed a negligible migration

Back to article page